EL
ATNM icon

EMFO LLC’s Actinium Pharmaceuticals ATNM Stock Holding History

EMFO LLC’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,666
Closed -$12K – 304
2022
Q3 		$12K Hold
1,666
– – 0.01% 249
2022
Q2 		$8K Hold
1,666
– – 0.01% 278
2022
Q1 		$9K Hold
1,666
– – 0.01% 281
2021
Q4 		$10K Hold
1,666
– – 0.01% 290
2021
Q3 		$15K Hold
1,666
– – 0.01% 282
2021
Q2 		$13K Buy
+1,666
New +$13.1K 0.01% 279

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EMFO LLC's ATNM Position: Q4 2022 in Review

EMFO LLC sold out of Actinium Pharmaceuticals (ATNM) in Q4 2022, closing a stake of 1,666 shares — an estimated $12K sold.

EMFO LLC first reported a position in ATNM in Q2 2021 and held it in 6 quarters. The position peaked at $15K in Q3 2021. 59 funds tracked by Wall St. Rank hold ATNM as of Q4 2022.

  • EMFO LLC reported no remaining Actinium Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • EMFO LLC sold 1,666 Actinium Pharmaceuticals shares in Q4 2022, an estimated $12K.
  • EMFO LLC first reported a position in Actinium Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • EMFO LLC's Actinium Pharmaceuticals position peaked at $15K in Q3 2021.
  • 59 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2022.

Based on EMFO LLC's 13F filing for Q4 2022, filed 2 Feb 2023.